DE LA AGUILERA LUIS 4
4 · USCB FINANCIAL HOLDINGS, INC. · Filed Jan 30, 2026
Research Summary
AI-generated summary of this filing
USCB CEO Luis De la Aguilera Exercises Options, Sells 10,000 Shares
What Happened
Luis De la Aguilera, President, CEO and a director of USCB Financial Holdings (USCB), exercised 10,000 stock options at $7.50 per share (cost $75,000) and sold 10,000 shares in the open market the same day for a weighted price of $18.02, generating proceeds of approximately $180,200. The Form 4 also records a separate exercise/conversion of 10,000 derivative shares reported at $0.00 (no proceeds) on the same date.
Key Details
- Transaction date: 2026-01-29 (filed with the SEC 2026-01-30). Filing was made promptly the next day.
- Exercise (code M): 10,000 shares at $7.50 — total cash paid $75,000.
- Sale (code S): 10,000 shares sold at a weighted price of $18.02 — proceeds ~$180,200. Per footnote F2, sale prices ranged $18.00–$18.16; the filer can provide per-price details on request.
- Additional derivative entry: 10,000 shares reported as exercised/converted at $0.00 and disposed (no proceeds) — treated as a derivative conversion/settlement in the filing.
- Shares owned after the transactions: not specified in the provided excerpt.
- Relevant footnotes: F1 lists several outstanding restricted stock grants and vesting schedules; F3–F5 describe option vesting schedules.
Context
Because the options were exercised and shares were sold the same day, this is effectively a cashless exercise — the insider converted options into shares and sold those shares in the open market. Sales by executives can be routine (liquidity or tax-related); this report is descriptive, not explanatory of motive.
Insider Transaction Report
- Exercise/Conversion
Class A Voting Common Stock
[F1]2026-01-29$7.50/sh+10,000$75,000→ 255,893 total - Sale
Class A Voting Common Stock
[F2][F1]2026-01-29$18.02/sh−10,000$180,200→ 245,893 total - Exercise/Conversion
Stock Option (Right to Buy)
[F3]2026-01-29−10,000→ 0 totalExercise: $7.50From: 2017-04-01Exp: 2026-04-01→ Common Stock (0 underlying)
- 40,000
Stock Option (Right to Buy)
[F4]Exercise: $11.35From: 2020-09-23Exp: 2029-09-23→ Common Stock (40,000 underlying) - 160,000
Stock Option (Right to Buy)
[F5]Exercise: $12.05From: 2022-09-27Exp: 2031-09-27→ Common Stock (160,000 underlying)
Footnotes (5)
- [F1]Includes the grant of 27,632 shares of restricted stock which vest at a rate of one-third per year commencing on January 27, 2027, 17,082 shares of restricted stock from a grant of 25,653 shares which commenced vesting at a rate of one-third per year on January 21, 2026, 4,045 shares of restricted stock from a grant of 12,136 shares which commenced vesting at a rate of one-third per year on January 22, 2025, 7,892 shares of restricted stock from a grant of 23,678 shares which commenced vesting at a rate of one-third per year on March 8, 2024, and 41,666 shares of restricted stock from a grant of 125,000 shares which commenced vesting at a rate of one-third per year on December 31, 2024.
- [F2]The price reported in column 4 is a weighted price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.16, inclusive. The reporting person undertakes to provide to USCB, or any security holder of USCB, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The stock options vested at the rate of 25% per year commencing on April 1, 2017.
- [F4]The stock options vested at the rate of one-third per year commencing on September 23, 2020.
- [F5]The stock options vested at the rate of one-third per year commencing on September 27, 2022.